{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T20:19:58Z","timestamp":1775420398719,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2021M693650"],"award-info":[{"award-number":["2021M693650"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00383-022-05126-x","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T10:12:50Z","timestamp":1650276770000},"page":"1031-1039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment optimization for recurrent hepatoblastoma: retrospective study from a hepatoblastoma cohort in Southern China"],"prefix":"10.1007","volume":"38","author":[{"given":"Yuanqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huadong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihai","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbiao","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"5126_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.29672","volume":"68","author":"A Hooks","year":"2018","unstructured":"Hooks A, Fazli L, Ernault D-S et al (2018) New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 68:89\u2013102. https:\/\/doi.org\/10.1002\/hep.29672","journal-title":"Hepatology"},{"key":"5126_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7\u201334. https:\/\/doi.org\/10.3322\/caac.21551","journal-title":"CA Cancer J Clin"},{"key":"5126_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jpedsurg.2017.03.017","volume":"52","author":"C Shi","year":"2017","unstructured":"Shi C, Masand H, Goss V (2017) Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg 52:956\u2013961. https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.03.017","journal-title":"J Pediatr Surg"},{"key":"5126_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/mph.0000000000000474","volume":"38","author":"AD Trobaugh-Lotrario","year":"2016","unstructured":"Trobaugh-Lotrario AD, Meyers RL, Feusner JH (2016) Outcomes of patients with relapsed hepatoblastoma enrolled on Children\u2019s Oncology Group (COG) phase i and ii studies. J Pediatr Hematol Oncol 38:187\u2013190. https:\/\/doi.org\/10.1097\/mph.0000000000000474","journal-title":"J Pediatr Hematol Oncol"},{"key":"5126_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/ped.14134","volume":"62","author":"C Zhang","year":"2020","unstructured":"Zhang C, Yao Li, Zhong L (2020) Novel treatment of refractory\/recurrent pulmonary hepatoblastoma. Pediatr Int 62:324\u2013329. https:\/\/doi.org\/10.1111\/ped.14134","journal-title":"Pediatr Int"},{"key":"5126_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/11597740-000000000-00000","volume":"14","author":"R Venkatramani","year":"2012","unstructured":"Venkatramani R, Furman WL, Fuchs J, Warmann SW, Malogolowkin MH (2012) Current and future management strategies for relapsed or progressive hepatoblastoma. Paediatr Drugs 14:221\u2013232. https:\/\/doi.org\/10.2165\/11597740-000000000-00000","journal-title":"Paediatr Drugs"},{"key":"5126_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.pedneo.2021.03.018","volume":"62","author":"JY Hou","year":"2021","unstructured":"Hou JY, Yeh TC, Huang TH, Sheu JC, Liu HC (2021) A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: a single institution experience. Pediatr Neonatol 62:400\u2013405. https:\/\/doi.org\/10.1016\/j.pedneo.2021.03.018","journal-title":"Pediatr Neonatol"},{"key":"5126_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12098-017-2301-9","volume":"84","author":"G Agarwala","year":"2017","unstructured":"Agarwala G, Bansal V, Prasad A et al (2017) Management of hepatoblastoma: ICMR consensus document. Indian J Pediatr 84:456\u2013464. https:\/\/doi.org\/10.1007\/s12098-017-2301-9","journal-title":"Indian J Pediatr"},{"key":"5126_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","volume":"49","author":"B Semeraro","year":"2013","unstructured":"Semeraro B, Maibach Z, Casanova B et al (2013) Relapses in hepatoblastoma patients: clinical characteristics and outcome\u2013experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). Eur J Cancer 49:915\u2013922. https:\/\/doi.org\/10.1016\/j.ejca.2012.10.003","journal-title":"Eur J Cancer"},{"key":"5126_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1080\/02656736.2020.1822549","volume":"37","author":"V Hetzer","year":"2020","unstructured":"Hetzer V, Entenmann H, Schullian P et al (2020) Stereotactic radiofrequency ablation of a variety of liver masses in children. Int J Hyperth 37:1074\u20131081. https:\/\/doi.org\/10.1080\/02656736.2020.1822549","journal-title":"Int J Hyperth"},{"key":"5126_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00270-018-2097-7","volume":"42","author":"C Yevich","year":"2019","unstructured":"Yevich C, Gravel F, Brugi\u00e8res V-C et al (2019) Reiterative radiofrequency ablation in the management of pediatric patients with hepatoblastoma metastases to the lung, liver, or bone. Cardiovasc Intervent Radiol 42:41\u201347. https:\/\/doi.org\/10.1007\/s00270-018-2097-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"5126_CR12","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1007\/s00261-019-02011-5","volume":"44","author":"Yu Cui","year":"2019","unstructured":"Cui Yu, Gu C, Liu D et al (2019) Microwave ablation assisted by three-dimensional visualization system as local therapy for relapsed hepatoblastoma: a small pilot study. Abdominal Radiol 44:2909\u20132915. https:\/\/doi.org\/10.1007\/s00261-019-02011-5","journal-title":"Abdominal Radiol"},{"key":"5126_CR13","first-page":"733","volume":"38","author":"Chinese Anti-Cancer Association Pediatric Committee, China Medical Association Pediatric Onco-surgery Group","year":"2017","unstructured":"Chinese Anti-Cancer Association Pediatric Committee, China Medical Association Pediatric Onco-surgery Group (2017) Expert consensus for multidisciplinary management of hepatoblastoma (CCCG-HB-2016). Chin J Pediatr Surg 38:733\u2013739","journal-title":"Chin J Pediatr Surg"},{"key":"5126_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"T Eisenhauer","year":"2009","unstructured":"Eisenhauer T, Bogaerts S, Sargent F et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"5126_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/s1470-2045(16)30598-8","volume":"18","author":"M Meyers","year":"2017","unstructured":"Meyers M, Hiyama H, Krailo R et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol 18:122\u2013131. https:\/\/doi.org\/10.1016\/s1470-2045(16)30598-8","journal-title":"Lancet Oncol"},{"key":"5126_CR16","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1080\/02656736.2021.1941310","volume":"38","author":"H Chen","year":"2021","unstructured":"Chen H, Ling Yu, Cheng L et al (2021) Percutaneous thermal ablation versus open liver resection for recurrent hepatoblastoma: a retrospective study. Int J Hyperth 38:1086\u20131091. https:\/\/doi.org\/10.1080\/02656736.2021.1941310","journal-title":"Int J Hyperth"},{"key":"5126_CR17","doi-asserted-by":"publisher","first-page":"16805","DOI":"10.1038\/srep16805","volume":"5","author":"Z Liu","year":"2015","unstructured":"Liu Z, Huang Z, Jiang S et al (2015) First experience of ultrasound-guided percutaneous ablation for recurrent hepatoblastoma after liver resection in children. Sci Rep 5:16805. https:\/\/doi.org\/10.1038\/srep16805","journal-title":"Sci Rep"},{"key":"5126_CR18","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1158\/2159-8290.CD-20-1809","volume":"11","author":"P Hirsch","year":"2021","unstructured":"Hirsch P, Morcrette R, Monteiro M et al (2021) Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer. Cancer Discov 11:2524\u20132543. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1809","journal-title":"Cancer Discov"},{"key":"5126_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"C Sumazin","year":"2017","unstructured":"Sumazin C, Trevi\u00f1o S, Hampton P et al (2017) Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65:104\u2013121. https:\/\/doi.org\/10.1002\/hep.28888","journal-title":"Hepatology"},{"issue":"346\u2013360","key":"5126_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"S Gay","year":"2021","unstructured":"Gay S, Park D, Groves H et al (2021) Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39(346\u2013360):e347. https:\/\/doi.org\/10.1016\/j.ccell.2020.12.014","journal-title":"Cancer Cell"},{"key":"5126_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","volume":"52","author":"H Czauderna","year":"2016","unstructured":"Czauderna H, Hiyama R, Krailo M et al (2016) The Children\u2019s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 52:92\u2013101. https:\/\/doi.org\/10.1016\/j.ejca.2015.09.023","journal-title":"Eur J Cancer"},{"key":"5126_CR22","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1007\/s00268-021-06289-9","volume":"45","author":"K Sato","year":"2021","unstructured":"Sato K, Suzushino K, Okada I et al (2021) Predicting post-hepatectomy liver failure using intra-operative measurement of indocyanine green clearance in anatomical hepatectomy. World J Surg 45:3660\u20133667. https:\/\/doi.org\/10.1007\/s00268-021-06289-9","journal-title":"World J Surg"},{"key":"5126_CR23","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/hep.31993","volume":"74","author":"Wu Chen","year":"2021","unstructured":"Chen Wu, Cheng W, Rong Wu et al (2021) Phase 2 study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with HCC. Hepatology 74:2595\u20132604. https:\/\/doi.org\/10.1002\/hep.31993","journal-title":"Hepatology"},{"key":"5126_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaoncol.2019.4477","volume":"6","author":"Li Xia","year":"2020","unstructured":"Xia Li, Liu W, Qian Lu et al (2020) Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma: a randomized clinical trial. JAMA Oncol 6:255\u2013263. https:\/\/doi.org\/10.1001\/jamaoncol.2019.4477","journal-title":"JAMA Oncol"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-022-05126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-022-05126-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-022-05126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T15:07:23Z","timestamp":1654182443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-022-05126-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5126"],"URL":"https:\/\/doi.org\/10.1007\/s00383-022-05126-x","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"1 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}